C
KURA icon

Covestor’s Kura Oncology KURA Stock Holding History

Covestor’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
43
+30
+231% +$283 ﹤0.01% 2674
2026
Q1 		$0 Buy
13
+1
+8% +$9 ﹤0.01% 2540
2025
Q4 		$0 Sell
12
-1
-8% -$10 ﹤0.01% 2510
2025
Q3 		$0 Hold
13
– – ﹤0.01% 2528
2025
Q2 		$0 Sell
13
-1
-7% -$6 ﹤0.01% 2483
2025
Q1 		$0 Buy
14
+8
+133% +$62 ﹤0.01% 2486
2024
Q4 		$0 Hold
6
– – ﹤0.01% 2495
2024
Q3 		$0 Hold
6
– – ﹤0.01% 2480
2024
Q2 		$0 Hold
6
– – ﹤0.01% 2498
2024
Q1 		$0 Sell
6
-4
-40% -$78 ﹤0.01% 2497
2023
Q4 		$0 Sell
10
-1
-9% -$10 ﹤0.01% 2432
2023
Q3 		$0 Buy
11
+4
+57% +$41 ﹤0.01% 2414
2023
Q2 		$0 Hold
7
– – ﹤0.01% 2405
2023
Q1 		$0 Hold
7
– – ﹤0.01% 2314
2022
Q4 		$0 Sell
7
-1
-13% -$15 ﹤0.01% 2339
2022
Q3 		$0 Buy
+8
New +$123 ﹤0.01% 2307

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Covestor's KURA Position: Q2 2026 in Review

Covestor increased its Kura Oncology (KURA) stake by 231% in Q2 2026, buying an estimated $283 and bringing the position to 43 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2674.

Covestor first reported a position in KURA in Q3 2022 and has held it in 16 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Covestor held 43 shares of Kura Oncology worth $0 as of Q2 2026.
  • Covestor bought 30 Kura Oncology shares in Q2 2026, an estimated $283.
  • Kura Oncology made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2674 holding.
  • Covestor first reported a position in Kura Oncology in Q3 2022 and has held it in 16 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.